OneMedNet's 15-minute chart has triggered a KDJ Death Cross and a Bearish Marubozu at 10/13/2025 13:45, indicating a shift in momentum towards a downward trend and potential further declines in the stock price. Sellers currently dominate the market, and bearish momentum is likely to persist.
OneMedNet Corp (NASDAQ: ONMD) has recently regained compliance with the Nasdaq Stock Market’s minimum bid price requirement, a critical milestone for its continued listing on the exchange. The company received written notice from Nasdaq staff on Tuesday, confirming that its common stock maintained a closing bid price of at least $1.00 per share for 10 consecutive business days from September 24 through October 7
OneMedNet regains compliance with Nasdaq minimum bid price requirement[1]. This compliance follows an earlier notice on April 10, when Nasdaq informed OneMedNet that it was not in compliance with the $1.00 minimum bid price requirement. The company was given until October 7 to regain compliance, which it has successfully done.
In addition to this regulatory milestone, OneMedNet has made several strategic moves to expand its reach in the healthcare AI and data analytics markets. The company has entered a multi-year partnership with Palantir Technologies to enhance its healthcare data analytics capabilities. This collaboration integrates Palantir’s Artificial Intelligence Platform with OneMedNet’s provider network, which accesses over 5 billion administrative claims and 131 million clinical exams across more than 1,750 provider sites. Additionally, OneMedNet has partnered with Medcase to venture into the healthcare data annotation market, creating a new revenue channel in the healthcare AI ecosystem. Furthermore, OneMedNet has secured a partnership with one of the world’s top five medical device companies, resulting in four purchase orders under an existing master services agreement
OneMedNet regains compliance with Nasdaq minimum bid price requirement[1].
Despite these positive developments, OneMedNet's stock has shown significant volatility. The shares have surged with a staggering 199% share price return over the past month and an even loftier 341% return in the last 90 days
A Look at OneMedNet (ONMD) Valuation Following Strategic Medcase Collaboration in Healthcare AI Data[2]. However, the company's price-to-book ratio currently stands at -31.2x, a stark outlier that diverges sharply from both industry peers and conventional valuation yardsticks. This negative equity indicates financial headwinds and challenges traditional valuation frameworks, potentially skewing future stock performance
A Look at OneMedNet (ONMD) Valuation Following Strategic Medcase Collaboration in Healthcare AI Data[2].
Recent technical analysis also suggests a shift in momentum towards a downward trend. OneMedNet's 15-minute chart has triggered a KDJ Death Cross and a Bearish Marubozu at 10/13/2025 13:45, indicating a potential further decline in the stock price . Sellers currently dominate the market, and bearish momentum is likely to persist.
Comments
No comments yet